172 related articles for article (PubMed ID: 10716716)
1. Human neuronal threonine-for-leucine-248 alpha 7 mutant nicotinic acetylcholine receptors are highly Ca2+ permeable.
Fucile S; Palma E; Mileo AM; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3643-8. PubMed ID: 10716716
[TBL] [Abstract][Full Text] [Related]
2. Strychnine activates neuronal alpha7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains.
Palma E; Fucile S; Barabino B; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13421-6. PubMed ID: 10557336
[TBL] [Abstract][Full Text] [Related]
3. Neuronal nicotinic threonine-for-leucine 247 alpha7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine.
Palma E; Maggi L; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9915-9. PubMed ID: 9275226
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of the neuronal alpha7 and L247T alpha7 mutant subunits yields hybrid nicotinic receptors with properties of both wild-type alpha7 and alpha7 mutant homomeric receptors.
Palma E; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1539-43. PubMed ID: 9037089
[TBL] [Abstract][Full Text] [Related]
5. Fractional Ca(2+) current through human neuronal alpha7 nicotinic acetylcholine receptors.
Fucile S; Renzi M; Lax P; Eusebi F
Cell Calcium; 2003 Aug; 34(2):205-9. PubMed ID: 12810063
[TBL] [Abstract][Full Text] [Related]
6. Threonine-for-leucine mutation within domain M2 of the neuronal alpha(7) nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist.
Palma E; Mileo AM; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):11231-5. PubMed ID: 8855338
[TBL] [Abstract][Full Text] [Related]
7. Effects of Zn2+ on wild and mutant neuronal alpha7 nicotinic receptors.
Palma E; Maggi L; Miledi R; Eusebi F
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10246-50. PubMed ID: 9707632
[TBL] [Abstract][Full Text] [Related]
8. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation.
Fucile S; Palma E; Eusebi F; Miledi R
Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of a mutated chicken alpha7 nicotinic acetylcholine receptor subunit with a leucine residue inserted in transmembrane domain 2.
Buckingham SD; Adcock C; Sansom MS; Sattelle DB; Baylis HA
Br J Pharmacol; 1998 Jun; 124(4):747-55. PubMed ID: 9690867
[TBL] [Abstract][Full Text] [Related]
10. Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
Xiao Y; Abdrakhmanova GR; Baydyuk M; Hernandez S; Kellar KJ
Acta Pharmacol Sin; 2009 Jun; 30(6):842-50. PubMed ID: 19448648
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nicotinic acetylcholine receptors by bicuculline.
Demuro A; Palma E; Eusebi F; Miledi R
Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.
Welsby P; Rowan M; Anwyl R
Eur J Neurosci; 2006 Dec; 24(11):3109-18. PubMed ID: 17156372
[TBL] [Abstract][Full Text] [Related]
13. Some properties of human neuronal alpha 7 nicotinic acetylcholine receptors fused to the green fluorescent protein.
Palma E; Mileo AM; Martinez-Torres A; Eusebi F; Miledi R
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3950-5. PubMed ID: 11891308
[TBL] [Abstract][Full Text] [Related]
14. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
Zwart R; Strotton M; Ching J; Astles PC; Sher E
Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886
[TBL] [Abstract][Full Text] [Related]
15. Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant.
Briggs CA; McKenna DG; Monteggia LM; Touma E; Roch JM; Arneric SP; Gopalakrishnan M; Sullivan JP
Eur J Pharmacol; 1999 Feb; 366(2-3):301-8. PubMed ID: 10082212
[TBL] [Abstract][Full Text] [Related]
16. Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
Papke RL
J Pharmacol Exp Ther; 2002 May; 301(2):765-73. PubMed ID: 11961083
[TBL] [Abstract][Full Text] [Related]
17. Activation and Ca2+ permeation of stably transfected alpha3/beta4 neuronal nicotinic acetylcholine receptor.
Zhang J; Xiao Y; Abdrakhmanova G; Wang W; Cleemann L; Kellar KJ; Morad M
Mol Pharmacol; 1999 Jun; 55(6):970-81. PubMed ID: 10347237
[TBL] [Abstract][Full Text] [Related]
18. Quercetin enhances human α7 nicotinic acetylcholine receptor-mediated ion current through interactions with Ca(2+) binding sites.
Lee BH; Choi SH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Lee JH; Kim HC; Park HY; Rhim H; Nah SY
Mol Cells; 2010 Sep; 30(3):245-53. PubMed ID: 20803082
[TBL] [Abstract][Full Text] [Related]
19. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
20. Involvement of alpha7- and alpha4beta2-type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons.
Matsubayashi H; Inoue A; Amano T; Seki T; Nakata Y; Sasa M; Sakai N
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):1-7. PubMed ID: 15469877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
